![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 21, 18868-18874, May 24, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Departments of
Received for publication, February 12, 2002, and in revised form, March 15, 2002
Specific cell-cell contacts establish and maintain the complex
architecture of tissues (1). These contacts are highly dynamic and
regulated during morphogenesis or tissue remodeling, and must be strong
enough to withstand mechanical stresses placed upon the tissue. In
polarized epithelial cells, three different types of cell-cell
junctions, tight junctions, adherens junctions, and desmosomes, are
aligned along the apical-basal axis of the lateral membrane.
In adherens junctions, classical cadherins function as homophilic
adhesion molecules. Clustering of cadherins and their attachment to the
actin cytoskeleton are key steps in the assembly of functional adherens
junctions. Cadherin clustering facilitates formation of lateral
cis-dimers between cadherin molecules on the same cell surface.
Cis-dimers have a much higher activity for adhesive trans-interaction between molecules on opposing cells (2-4). Anchorage to the
cytoskeleton may promote cis-dimerization and higher order clustering
and thereby contribute to strengthening of cell adhesion (5, 6).
Linkage of classical cadherins to the cytoskeleton is mediated by
proteins termed catenins. In adherens junctions of polarized epithelial cells, the
nectin/afadin/ponsin (NAP)1
cell adhesion system colocalizes with cadherins (16, 17). Nectin is a
homophilic cell adhesion protein of the immunoglobulin superfamily.
Afadin, an F-actin-binding protein, contains a PDZ domain that binds to
the cytoplasmic domain of nectin (16, 18). Afadin exists in two splice
variants: l-afadin is expressed ubiquitously, whereas s-afadin is found
only in neural tissues (18). Like cadherins, nectin forms cis-dimers,
which might be required for trans-interactions (19). Binding of afadin
to the cytoplasmic domain of nectin is not required for cis- or
trans-interactions, but it is required for clustering of nectin
molecules in cell-cell contact sites and for colocalization of the NAP
adhesion system with cadherins (19). Analysis of afadin ( The colocalization of the NAP adhesion system with adherens junctions
depends upon afadin and We present here the structure of a proteolytically derived fragment of
Construction of Expression Vectors--
Full-length Protein Expression and Purification--
GST-full-length
To incorporate selenomethionine into the Crystallization and Data Collection--
Crystals of
selenomethionine-labeled
Diffraction data were measured from a single crystal at beamline 1-5
of the Stanford Synchroton Radiation Laboratory. Complete data to 2.5 Å Bragg spacings were collected at four wavelengths at 120 s per
1° exposure on an ADSC Quantum 4 CCD detector. Data were integrated
and scaled using Denzo and Scalepack (30). Data collection statistics
are presented in Table I.
Structure Determination and Refinement--
Patterson and
phasing calculations were performed with the program CNS (31); model
building was done with the program O (32). An automated Patterson
search revealed five sites, and two additional sites were identified
from anomalous and dispersive difference Fourier maps calculated with
phases made from the five-site model, giving a total of 7 out of 21 possible sites. Solvent flipping did not significantly improve the
phases and was therefore not used. The electron density map calculated
from the multiwavelength anomalous dispersion phases was of
sufficient quality to assign the sequence for most of the model. To
reduce model bias, the initial rounds of refinement were carried out
using the complex structure factors (MLHL target in CNS). After seven
rounds of refinement the model was refined against the edge data set
with a maximum likelihood target using amplitudes only. Bulk solvent and anisotropic temperature factor corrections were applied during all
rounds of refinement. After several rounds of minimization and two
rounds of simulated annealing, all side chains could be placed.
Non-crystallographic symmetry restraints, even at a low weight,
resulted in higher R-factors and were therefore not used. Individual temperature factors were refined in the later stages of
refinement. The limited resolution precluded extensive modeling of
water molecules, but a limited number of water molecules could be
identified as Fo Cross-linking Experiments--
Purified protein was concentrated
and dialyzed against 100 mM HEPES, pH 8.0; dilutions
required to adjust the protein concentration were made with the same
buffer. In a final reaction volume of 30 µl, protein samples were
incubated for 1 h at room temperature with a 30-fold excess of the
cross-linker DMS (dimethyl suberimidate) or BS3
(bis(sulfosuccinimidyl)suberate) (Pierce). After incubation, samples
were immediately boiled in gel loading buffer and separated on a 12%
polyacrylamide gel in the case of Afadin Binding Assays--
MDCK cells were cultured in
Dulbecco's modified Eagle's medium, supplemented with 10% (v/v)
heat-inactivated fetal calf serum at 37 °C in 10% CO2
atmosphere. Approximately 70% confluent MDCK cells were washed twice
with ice-cold phosphate-buffered saline, containing 50 µM
CaCl2. Cells were scraped from the plate into ice-cold
phosphate-buffered saline and pelleted by centrifugation at 2000 × g for 5 min at 4 °C. The pellet was resuspended in
Nonidet P-40 lysis buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Nonidet P-40, 1 mM DTT, 0.2 mM phenylmethylsulfonyl
fluoride, and 0.2 mM benzamindine), and the cells
were lysed for 30 min on ice. The lysate was cleared by centrifugation
for 30 min at 1600 × g at 4 °C. GST fusion proteins
were coupled to glutathione-agarose at a concentration of 4.75 × 10 Actin Cosedimentation Assay--
Monomeric rabbit skeletal
muscle actin (Cytoskeleton Inc., Denver, CO) was stored in 5 mM Tris, pH 8.0, 0.2 mM CaCl2, 0.5 mM DTT, and 0.2 mM ATP at a concentration of
0.4 mg/ml (9.5 µM). 50-µl aliquots were polymerized by
addition of 5 µl of 10-fold concentrated actin polymerization buffer
(500 mM KCl, 20 mM MgCl2, and 10 mM ATP) and incubation for 1 h at room temperature.
Protein stocks used in the following step were precleared by
centrifugation at 436,000 × g for 7 min to exclude
cosedimentation of aggregates. After the addition of 5 µl of protein
stock solution (100 µM) to the polymerized actin
aliquots, samples were incubated for 30 min at room temperature.
Protein bound to F-actin was separated from unbound protein by
centrifugation at 436,000 × g at 4 °C for 7 min. 30 µl of the supernatant were mixed with 10 µl of 4× gel loading
buffer, boiled, and loaded on a 12% polyacrylamide gel. The pellet was
resuspended in 60 µl of gel loading buffer, boiled, and 30 µl were
loaded onto a gel. Gels were stained with Coomassie Blue.
Structure of
The structure of
The small interaction interface between the two four-helix bundles
(varying between 464 and 697 Å2) appears to allow for
flexibility between the two domains. In the three crystallographically
independent views of the molecule, the relative orientation of the two
subdomains differs by up to 14°. In the recently published structure
of the Oligomeric State of
To assess the possible relevance of the crystallographically observed
oligomers, we examined the properties of the The Actin-binding Domain of The proper organization of adherens junctions in epithelial cells
involves the clustering and cytoskeletal anchorage of cadherin molecules and their colocalization with the nectin adhesion system (20). The structure of the proteolytically defined The relative orientation of the two four-helix bundles of the
We have shown that The structural and biochemical data presented here suggest two possible
mechanisms for regulating l-afadin binding. In one scenario, the open
and closed conformations observed in the crystals of Conformational changes leading to the exposure of the l-afadin-binding
site in the full-length protein could in principle be regulated by a
variety of possible mechanisms, such as
phosphorylation/dephosphorylation or the interaction with other
Cryptic binding sites have been identified in several other proteins
that are involved in tethering of transmembrane proteins to the actin
cytoskeleton. Interactions between the head and tail domain of vinculin
mask binding sites on both domains (36). The C-terminal actin-binding
domain of vinculin forms a five-helix bundle, which appears to open to
a less tightly packed conformation when bound to F-actin (26). It has
been suggested that the interaction between head and tail domain
prevents this conformational change and thereby allosterically controls
association of vinculin with F-actin (26). Similarly, in proteins of
the ERM (ezrin/radixin/moesin) family, interaction between the FERM
head domain and the tail domain masks the binding sites for other
proteins (37), and conformational activation involves a weakening of
the head-to-tail interaction. In ERM proteins the association of head
and tail domain determines the conformation of the tail domain, and it has been suggested that the tail domain adopts a different conformation when it binds to actin (38).
Vinculin shares sequence and most likely structural similarity with
We thank S. Fridman for technical assistance
and H. Bellamy for beamline support.
*
This work was supported by Grants GM35227 (to W. J. N.) and GM56169 (to W. I. W.) from the National
Institutes of Health. Portions of this work were carried out at the
Stanford Synchrotron Radiation Laboratory (SSRL), a national user
facility operated by Stanford University on behalf of the United States
Department of Energy, Office of Basic Energy Sciences. The SSRL
Structural Molecular Biology Program is supported by the Department of
Energy, Office of Biological and Environmental Research, and by the
National Institutes of Health, National Center for Research Resources, Biomedical Technology Program, and the National Institute of General Medical Sciences.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The atomic coordinates and the structure factors (code 1L7C) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
Published, JBC Papers in Press, March 20, 2002, DOI 10.1074/jbc.M201463200
2
Y. T. Chen and W. J. Nelson,
unpublished data.
The abbreviations used are:
NAP, nectin/afadin/ponsin;
GST, glutathione S-transferase;
DTT, dithiothreitol;
MDCK, Madin-Darby canine kidney;
ERM, ezrin/radixin/moesin;
DMS, dimethyl suberimidate.
Biochemical and Structural Definition of the l-Afadin- and
Actin-binding Sites of
-Catenin*
§,
§
Structural Biology and
§ Molecular and Cellular Physiology, Stanford University
School of Medicine, Stanford, California 94305 and the
¶ Department of Molecular Biology and Biochemistry, Osaka
University Graduate School of Medicine, Suita 565-0871, Japan
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-Catenin is an integral component of adherens
junctions, where it links cadherins to the actin cytoskeleton.
-Catenin is also required for the colocalization of the
nectin/afadin/ponsin adhesion system to adherens junctions, and it
specifically associates with the nectin-binding protein afadin. A
proteolytic fragment of
-catenin, residues 385-651, contains the
afadin-binding site. The three-dimensional structure of this fragment
comprises two side-by-side four-helix bundles, both of which are
required for afadin binding. The
-catenin fragment 385-651 binds
afadin more strongly than the full-length protein, suggesting that the
full-length protein harbors a cryptic binding site for afadin.
Comparison of the
-catenin 385-651 structure with the recently
solved structure of the
-catenin M-fragment (Yang, J., Dokurno, P.,
Tonks, N. K., and Barford, D. (2001) EMBO J. 20, 3645-3656) reveals a surprising flexibility in the orientation of the
two four-helix bundles.
-Catenin and the actin-binding protein
vinculin share sequence and most likely structural similarity within
their actin-binding domains. Despite this homology, actin binding
requires additional sequences adjacent to this region.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-Catenin and plakoglobin (
-catenin) both bind in a mutually exclusive manner to the cytoplasmic domain of
classical cadherins, and interact with
-catenin (7, 8).
-Catenin
links the cadherin-
-catenin/plakoglobin complex to the cytoskeleton
either through direct binding to F-actin (9) or indirectly through the
interaction with the actin-binding proteins vinculin,
-actinin,
ZO-1, or ZO-2 (10-14). Additionally,
-catenin interacts with
spectrin, which might play a role in assembly of the cortical spectrin
cytoskeleton (15). The diversity of these binding partners indicates
that
-catenin plays a key role in assembly of adherens junctions.
/
) mice
shows that afadin is essential for proper organization of adherens
junctions and tight junctions in epithelial cells (20).
-catenin (21). However, initial attempts to
demonstrate a direct interaction between afadin and
-catenin using
recombinant full-length proteins failed (22). Recently a direct
interaction between the C-terminal half of
-catenin and afadin was
shown by yeast two hybrid and in vitro binding analysis
(21). The observation that a truncated form, but not full-length
-catenin, binds to afadin suggests that afadin binding is regulated
through exposure of a cryptic binding site in
-catenin.
-catenin, residues 385-651, and demonstrate that it comprises the
l-afadin-binding site. Structural and biochemical data suggest
mechanisms for unmasking the cryptic l-afadin-binding site in
-catenin.
-Catenin is homologous to the actin-binding protein
vinculin. Structural similarity has been proposed for the two proteins
for more than 80% of their sequence (23-27). Despite strong sequence
homology between the actin-binding region of vinculin and a C-terminal
portion of
-catenin, we show that
-catenin requires additional
sequences for binding to actin.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-catenin
used in the limited proteolysis experiment was expressed with a
C-terminal His6-tag (28); for expression of the N-terminal
GST fusion protein, full-length
-catenin was inserted into the
pGEX-KG vector, a modified form of pGEX-2T (Amersham Biosciences), in which a linker of 5 glycine residues is
introduced between the thrombin cleavage and the multiple cloning sites
(29).2 All
-catenin
fragments were amplified by PCR.
-Catenin 385-651 and
-catenin
385-507 were cloned into the pGEX-2T expression vector (Amersham
Biosciences).
-Catenin 632-906,
-catenin 671-906, and
-catenin 678-864 were cloned into the pGEX-4T-3 vector (Amersham Biosciences), and
-catenin 507-632 was introduced into the pGEX-KG vector.
-catenin was expressed in E. coli Ab1899 cells, and all
other GST fusion proteins were expressed in E. coli BL21
cells. Bacteria were grown at 37 °C in LB in the presence of 100 µg/ml ampicillin until an A600 of
0.8-1.0 was reached. Cells were induced with 1 mM
isopropyl-g-D-thiogalactopyranoside and grown for an
additional 4 h. After centrifugation, the pelleted cells were
resuspended in 50 mM Tris, pH 8.0, containing 2 mM EDTA, 0.1% Triton X-100, 1 mM DTT, 2.5 mM phenylmethylsulfonyl fluoride, 2.5 µg/ml
aprotinin, 5 µg/ml pepstatin, and lysed by passage through a French
pressure cell. The lysate was cleared by centrifugation and
subsequently incubated with glutathione-agarose for 1 h at
4 °C.
-Catenin 385-651,
-catenin 385-507, and
-catenin 507-632 were cleaved from the GST-tag with trypsin
(L-1-tosylamido-2-phenylethyl chloromethyl ketone
(TPCK)-treated, Sigma) (4.8, 48, and 240 units/ml of 50% beads,
respectively, for 1 h at room temperature), whereas
-catenin
632-906,
-catenin 671-906, and
-catenin 678-864 were cleaved
with bovine thrombin (Sigma) (1.1, 6.6, and 7.6 units/ml of 50% beads
for 1 h at room temperature). GST fusion proteins were eluted from
the beads with 20 mM Tris, pH 8.5, 150 mM NaCl, 1 mM DTT, 50 mM reduced glutathione. The
proteins were further purified by anion exchange chromatography (Mono Q
column, Amersham Biosciences) or in case of
-catenin 678-864 and
-catenin 671-906 by cation exchange chromatography (Mono S,
Amersham Biosciences).
-catenin 385-651 fragment,
the expression vector was transformed into the methionine auxotroph
strain B834 (Novagen). Cells were grown in defined medium containing
250 µM selenomethionine and supplemented with Kao and Michayluk vitamin solution (Sigma).
-catenin 385-651 were grown at room
temperature in an anaerobic chamber by the hanging drop vapor diffusion
method, by mixing 1 µl of a 80 mg/ml protein solution with 1 µl of
the well solution containing 700 mM sodium acetate, pH 4.0, 10 mM dithiothreitol, 1.05 M urea, 200 mM sodium/potassium tartrate, and 3% isopropanol. Crystals
grew from a heavy precipitate. Crystals were adapted for cryoprotection
by transfer into synthetic mother liquor solutions containing 5% step
increases of ethylene glycol to a final concentration of 30% and
frozen in a 100 K nitrogen gas stream. The crystals belong to the
space group P212121 with unit cell
dimension a = 64.8 Å, b = 105.3 Å,
and c = 123.9 Å. There are three molecules in the
asymmetric unit, corresponding to a solvent content of 48%. Typical
dimensions of the crystals were 200 × 200 × 150 µm.
Fc peaks
above 3 standard deviations with sensible hydrogen bonding geometry.
Phasing and refinement statistics are shown in Table I.
-catenin 385-651 and a 15%
polyacrylamide gel in case of the two smaller fragments. Gels were
stained with Coomassie Blue.
9 M/200 µl of 50% bead suspension. 80 µl of a 50% bead suspension were incubated for 2 h at 4 °C
with lysate obtained from two 15-cm diameter culture plates. Beads were
washed four times with 500 µl of Nonidet P-40 lysis buffer and boiled
in 40 µl of SDS loading buffer. Samples were run on a 7%
polyacrylamide gel and subsequently electroblotted onto a
nitrocellulose membrane. After blocking with 20 mM Tris, pH
7.5, 100 mM NaCl, 0.1% Tween 20 containing 5% nonfat dry
milk, the membranes were incubated with a monoclonal mouse
anti-l-afadin antibody, followed by incubation with a secondary horseradish peroxidase-coupled anti-mouse antibody. Bands were visualized with the ECL detection system (Amersham Biosciences).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-Catenin 385-651--
Limited proteolysis was
used to define stable fragments of
-catenin (25). Incubation of
full-length
-catenin with trypsin results in the accumulation of two
fragments that encompass residues 82-287 and residues 385-651. The
-catenin 82-279 fragment constitutes the dimerization and
-catenin-binding region of
-catenin, whose structure and
interactions with
-catenin were described previously (25).
The structure of
-catenin 385-651 was solved by multiwavelength anomalous dispersion phasing and refined to 2.5-Å resolution (Table I). There are three copies of the
molecule in the asymmetric unit, which are related by a 91o
and a 112o rotation. The final model consists of residues
388-601 and 606-631 for copy A, residues 391-562, 566-597, and
607-631 for copy B, and residues 393-600 and 607-631 for copy C. Residues 632-651 are never observed, indicating that they are
disordered, which is consistent with the presence of a tryptic cleavage
site at residue 633 (27).
Crystallographic data
-catenin 385-651
-catenin 385-651 consists of two four-helix
bundles that lie at a relative angle of ~40° (Fig.
1A). The first helix in the
N-terminal four-helix bundle is shorter than the remaining three (11 residues compared with 26-30 residues). Residues preceding amino acid
396 turn away from the four-helix bundle, and residues 385-390 and
385-392 in copies B and C are not visible, indicating that this region
is flexible. In both four-helix bundles, the third helix contains a
proline residue, which causes a prominent kink. The proline in the
C-terminal four-helix bundle additionally causes the turn preceding the
proline to bulge (Fig. 1A).

View larger version (32K):
[in a new window]
Fig. 1.
Structure of
-catenin 385-651. A, ribbon
diagram of the structure; the two views of the molecule rotated by
180o. The N- and C-terminal four-helix bundles are colored
in red and blue, respectively. These subdomains
correspond to the N- and C-terminal fragments used in cross-linking and
afadin binding studies. The positions of proline residues within the
helices are indicated by an arrow. B, relative
motion of the N- and C-terminal subdomains of
-catenin 385-651. The
N-terminal subdomains of the
-catenin 385-651 fragment
(yellow) and the
-catenin M fragment (Ref. 27; residues
377-633) (blue) were superimposed. The relative orientation
of the N- and C-terminal domain varies in the five different views
obtained from the two different crystal forms. The two copies shown
here show the largest angular displacement between the two four-helix
bundles. The figure was prepared using MOLSCRIPT (39) and RASTER3D
(40).
-catenin M-fragment (27), residues 377-633, the asymmetric
unit contains two copies of the molecule; in both, the two domains
assume an almost perpendicular orientation and their disposition with
respect to each other varies by 10°. Comparison of the two crystal
structures shows that the angle between the two bundles varies up to
56° (Fig. 1B). The relative orientation of the two domains
therefore exhibits a much wider range than expected from the single
structures. The "closed" conformation seen in the present structure
is stabilized by side by side interactions between the two four-helix
bundles, whereas the "open" conformation seen in the M-fragment is
stabilized by interactions between the bases of the four-helix bundles.
In both the closed and the open conformations, the number of contacts between the two four-helix bundles is rather small, and the maximum surface area buried between the bundles is 697 and 680 Å2, respectively.
-Catenin 385-651--
-Catenin 385-651
and the
-catenin M-fragment (27) (residues 377-633) were
crystallized under different conditions and in two different crystal
forms. In each case there are multiple copies of the molecule in the
asymmetric unit. The surface area buried between molecules is 866, 1788, and 2317 Å2 between copies A and C, A and B, and B
and C, respectively, in the
-catenin 385-651 crystals. In the
-catenin 377-633 crystals, 1280 Å2 of
solvent-accessible surface area is buried in the
non-crystallographic dimer interface. Although the dimers seen in
the M-fragment crystals (27) are formed by two molecules in the open
conformation, modeling indicates that the dimer interactions would be
possible in the closed conformation. Conversely, the trimers observed
in the present crystals are formed by molecules in the closed
conformation; molecules in the open conformation could not form the
trimer interactions without steric clashes.
-catenin 385-651
fragment in solution. Oligomerization of
-catenin 385-651 or
377-633 cannot be detected by gel filtration chromatography (data not
shown; see also Ref. 27). However, a small fraction of
-catenin
385-651 can be cross-linked to dimers and trimers at protein
concentrations above 100 µM (Fig.
2). Cross-linking to dimers and trimers
is also observed with
-catenin 377-633 (27). The contacts seen in
the asymmetric unit of the
-catenin 385-651 crystals mostly involve
the N-terminal four-helix bundle, whereas those observed in the
-catenin 377-633 crystals solely involve interactions between the
C-terminal four-helix bundles (27). We expressed the N- and C-terminal
domains separately and confirmed their correct folding by circular
dichroism spectroscopy (data not shown). Consistent with the crystal
packing, the C-terminal bundle (residues 507-632) can be cross-linked
to dimers at protein concentrations above 20 µM, whereas
for the N-terminal domain
-catenin 385-507 cross-links to trimers,
but not to dimers, at concentrations above 100 µM (Fig.
2).

View larger version (29K):
[in a new window]
Fig. 2.
Oligomerization of
-catenin 385-651 and its N- and C-terminal
subdomains. Fragments at the indicated concentrations were
incubated with a 30-fold excess of cross-linker. For the two
amine-reactive cross-linking reagents BS3 and DMS with spacer arms of
11.4 and 11.0 Å, respectively, different cross-linking efficiency was
observed. Higher cross-linking efficiency results are shown here and
were obtained with DMS in the case of
-catenin 507-632 and
BS3 for
-catenin 385-651 and
-catenin 385-507. The first
lane for the
-catenin 385-651 fragment shows a sample in the
absence of cross-linker. Molecular mass markers are indicated on
the left of each gel, and apparent molecular mass of
the fragments and cross-linking products are shown on the
right.
-Catenin 385-651 Includes the l-Afadin-binding Site--
Yeast
two-hybrid and in vitro binding assays have shown that the
C-terminal half of
-catenin,
-catenin 509-906, interacts directly with l-afadin (21). To more precisely map the 1-afadin-binding site on
-catenin, different GST-
-catenin fusion proteins were coupled to glutathione-agarose beads and incubated with MDCK cell lysate. Binding of l-afadin was assessed by Western blotting (Fig. 3B). The C-terminal
-catenin fragment used in previous binding studies (21) includes the
second four-helix bundle of
-catenin 385-651, so we tested
-catenin 385-651 for l-afadin binding. To assess the contribution
of the C terminus of
-catenin we generated two C-terminal fragments
(Fig. 3A). In the structure of
-catenin 385-651, the
last ordered residue is 631, and we therefore prepared a construct
comprising residues 632-906. This fragment degraded to a smaller
fragment starting at residue 671 during thrombin cleavage of the GST
fusion protein, so a second construct encompassing residue 671-906 was
also prepared and tested. No binding was detectable for
-catenins
632-906 and 671-906 or the GST control, whereas
-catenin 385-651
clearly bound l-afadin (Fig. 3B). In our binding assay 1%
of the total amount of l-afadin detected in the cell extract was found
to be bound to
-catenin 385-651. To further refine the
l-afadin-binding site, GST fusion proteins of the N- and C-terminal
four-helix bundle subdomains of the fragment were prepared and tested
in the same binding assay (Fig. 3C). The interaction of
l-afadin with the N-terminal four-helix bundle was barely detectable, whereas l-afadin bound to the C-terminal four-helix bundle. However, compared with the
-catenin 385-651 fragment, this interaction is
significantly weaker. Combined with the observation that the N-terminal
half of
-catenin,
-catenin 1-508, does not bind to l-afadin,
these data indicate that
-catenin 385-651 constitutes the full
binding site for l-afadin. We were also able to detect l-afadin binding
to full-length
-catenin (Fig. 3, B and C).
However, significantly less l-afadin bound to the full-length protein
compared with the fragment
-catenin 385-651.

View larger version (24K):
[in a new window]
Fig. 3.
Interaction of
-catenin with l-afadin. A,
schematic representation of the different
-catenin fragments used in
the binding assays. B, proteins expressed as GST fusion
proteins were coupled to glutathione-agarose beads and incubated with
MDCK cell lysate. Bound protein was analyzed by Western blotting using
monoclonal anti-afadin antibody. The signal for l-afadin in 15 µl of
MDCK lysate, which corresponds to 1% of the amount used in the binding
assays, is shown in the right lane. Molecular mass
markers are shown on the left. C, binding to the
N- and C-terminal subdomains of
-catenin 385-651.
-Catenin--
The actin-binding
site of
-catenin has been mapped by in vitro binding
assays to residues 461-906 (9) and has been further narrowed down to
residues 697-906 by in vivo actin colocalization studies
(12).
-Catenin is homologous to the F-actin-binding protein
vinculin, and the region of strongest homology corresponds to the
C-terminal actin-binding domain of vinculin. We tested three C-terminal
fragments of
-catenin for F-actin binding:
-catenin 632-906 and
-catenin 671-906 (see above) and
-catenin 678-864. The borders
of
-catenin 678-864 were chosen by homology to the vinculin tail
domain (26) (Fig. 4A). Proper
folding was assessed by circular dichroism spectroscopy for
-catenin
631-906 and 678-864 (data not shown). Whereas the two fragments that
extend to the very C terminus of
-catenin both bind to F-actin,
-catenin 678-864 does not cosediment with actin (Fig.
4B). Therefore, it appears that the C-terminal 42 amino
acids of
-catenin that extend beyond the vinculin homology region
are required for binding to F-actin.

View larger version (37K):
[in a new window]
Fig. 4.
Interaction of
-catenin (
-cat) with
F-actin. A, schematic representation of
-catenin and
the constructs used in the binding assay. Vinculin homology regions are
shown in dark gray. B, binding to F-actin was
examined by cosedimentation. Assuming a binding ratio of
protein:monomeric actin of 1:7, all
-catenin constructs were added
in excess. The supernatant (S) containing the unbound
protein and the pellet (P) containing F-actin and bound
protein are shown for each sample. Molecular mass markers are indicated
on the left.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-Catenin binds to F-actin and to l-afadin and thus has essential roles in these processes. In the studies presented here, the
regions of
-catenin responsible for binding to l-afadin and F-actin
have been defined biochemically and structurally.
-catenin fragment,
-catenin 385-651, consists of two adjacent four-helix bundles. Each
four-helix bundle has the ability to oligomerize. Packing of molecules
in the crystals and cross-linking experiments indicate that at high
concentrations the N-terminal bundle can trimerize, whereas the
C-terminal bundle can dimerize. These results are consistent with the
observation that the entire fragment can be crosslinked to dimers and
trimers (27) (Fig. 2). The size of most of the interfaces between the
different copies of the protein in the crystallographic asymmetric unit
are in a range typical for specific protein-protein interactions (33).
However, the contacts are unique to each crystal form. Furthermore,
oligomerization cannot be detected by gel filtration chromatography,
which indicates a low affinity interaction. Therefore, the biological
significance of this self-association remains unclear. Amino acids
509-643, which comprise the C-terminal four-helix bundle, have been
shown to play a significant role in modulating cell adhesion (14). This
function might be related to the ability of the C-terminal domain to
dimerize, which might ultimately cause a clustering of cadherin cell
adhesion molecules (27).
-catenin 385-651 fragment exhibits a surprising variability, which
is likely due to the small number of contacts between these two
subdomains. Within one crystal form, the inter-bundle angles vary
modestly, up to 14°. More strikingly, comparison of the structure in
the present crystal form to that of the M-fragment (27) shows that the
angular arrangement changes from a relative rotation of about 40°
(the closed conformation) to an approximately perpendicular arrangement
of the two bundles (the open conformation) (Fig. 1B). Each
of these conformations is stabilized by a different set of interdomain
contacts, and conformations in which neither set of contacts are
present are likely to be energetically less favorable. It is tempting
to speculate that a switch between these two conformations mediates a
regulatory function, although it is possible that steric hindrance by
other domains in the full-length molecule restricts this large
interdomain movement.
-catenin 385-561 includes the full binding site
for l-afadin. The observation that the isolated four-helix bundles bind
no or less l-afadin than the entire fragment indicates that both
four-helix bundles contribute to the l-afadin-binding site. Full-length
-catenin bound significantly less l-afadin than the
-catenin
fragment 385-651. In a previous study, only the C-terminal half of
-catenin (residues 508-906), but not the full-length protein, bound
to l-afadin (21). Those experiments, which included yeast two-hybrid
analysis and in vitro binding assays with recombinant
proteins and subsequent protein detection by Coomassie staining, might
not have been sensitive enough to detect the binding of full-length
protein (21). Collectively, these data indicate that there is a cryptic
binding site for l-afadin in full-length
-catenin.
-catenin
385-651 and
-catenin 377-633 (27) represent active and inactive
states for l-afadin binding. In this case, the switch between these
conformations would affect the l-afadin binding surface formed by the
two four-helix bundles. In the full-length protein, other domains could
impose steric constraints on the switch between open and closed
conformation and thereby cause a reduction in l-afadin binding, whereas
the two conformations might be more easily interchangeable in the
fragment. Alternatively, the arrangement of other domains in the
full-length protein might not allow the large interdomain movement
observed in the crystals, so that the l-afadin-binding region possesses
only one conformation. In this case, the observation that the
l-afadin-binding site is flexibly linked to the flanking regions of
-catenin, as indicated by proteolytic sensitivity (25), suggests
that interdomain movements regulate access to the l-afadin-binding site.
-catenin-binding proteins. In addition, self-association, either
through the N-terminal
-catenin dimerization domain (25) or through
the l-afadin-binding domain described above, could affect accessibility
of the l-afadin-binding site. For example,
-catenin forms a dimer in
solution which dissociates upon binding to
-catenin (25, 34), and
-actinin binds to
-catenin only when
-catenin is associated
with
-catenin (35). This observations might indicate the presence of
a cryptic binding site for
-actinin that is masked in the
-catenin dimer and activated through
-catenin binding.
-catenin, including the portion of the
-catenin dimerization and
the afadin-binding domain (25, 27). The two proteins share the highest
degree of sequence identity within the actin-binding domain of vinculin
(27%), which is a five-helix bundle (26, 27). However,
-catenin
contains an additional 42 amino acids C-terminal to the bundle homology
region. Deletion of these amino acids impairs actin binding (Fig.
4B) but does not affect folding of
-catenin 678-864.
This result indicates that the C-terminal 42 amino acids are involved
directly in actin binding. In contrast to vinculin, the actin-binding
site in
-catenin is not masked, and binding affinities for the
-catenin-actin interaction are about 10-fold higher for the
full-length protein (about 0.3 µM) compared with a
fragment that includes the C-terminal 447 amino acids (about 3 µM) (9). Taken together, these data indicate that even
though
-catenin and vinculin share sequence and probably structural
similarity, the two proteins differ in their interaction with
F-actin.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
To whom correspondence should be addressed: Dept. of
Structural Biology, Stanford University School of Medicine, Fairchild Bldg., 299 Campus Dr. West, Stanford, CA 94305. Tel.: 650-725-4623; Fax: 650-723-8464; E-mail: bill.weis@stanford.edu.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Gumbiner, B. M.
(1996)
Cell
84,
345-357[CrossRef][Medline]
[Order article via Infotrieve]
2.
Tomschy, A.,
Fauser, C.,
Landwehr, R.,
and Engel, J.
(1996)
EMBO J.
15,
3507-3514[Medline]
[Order article via Infotrieve]
3.
Brieher, W. M.,
Yap, A. S.,
and Gumbiner, B. M.
(1996)
J. Cell Biol.
135,
487-496 4.
Steinberg, M. S.,
and McNutt, P. M.
(1999)
Curr. Opin. Cell Biol.
11,
554-560[CrossRef][Medline]
[Order article via Infotrieve]
5.
Adams, C. L.,
Nelson, W. J.,
and Smith, S. J.
(1996)
J. Cell Biol.
135,
1899-1911 6.
Angres, B.,
Barth, A.,
and Nelson, W. J.
(1996)
J. Cell Biol.
134,
549-557 7.
Ozawa, M.,
and Kemler, R.
(1992)
J. Cell Biol.
116,
989-996 8.
Jou, T. S.,
Stewart, D. B.,
Stappert, J.,
Nelson, W. J.,
and Marrs, J. A.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
5067-5071 9.
Rimm, D. L.,
Koslov, E. R.,
Kebriaei, P.,
Cianci, C. D.,
and Morrow, J. S.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
8813-8817 10.
Itoh, M.,
Nagafuchi, A.,
Moroi, S.,
and Tsukita, S.
(1997)
J. Cell Biol.
138,
181-192 11.
Itoh, M.,
Morita, K.,
and Tsukita, S.
(1999)
J. Biol. Chem.
274,
5981-5986 12.
Weiss, E. E.,
Kroemker, M.,
Rudiger, A. H.,
Jockusch, B. M.,
and Rudiger, M.
(1998)
J. Cell Biol.
141,
755-764 13.
Watabe-Uchida, M.,
Uchida, N.,
Imamura, Y.,
Nagafuchi, A.,
Fujimoto, K.,
Uemura, T.,
Vermeulen, S.,
van Roy, F.,
Adamson, E. D.,
and Takeichi, M.
(1998)
J. Cell Biol.
142,
847-857 14.
Imamura, Y.,
Itoh, M.,
Maeno, Y.,
Tsukita, S.,
and Nagafuchi, A.
(1999)
J. Cell Biol.
144,
1311-1322 15.
Pradham, D.,
Lombardo, C. R.,
Roe, S.,
Rimm, D. L.,
and Morrow, J. S.
(2001)
J. Biol. Chem.
276,
4175-4181 16.
Takahashi, K.,
Nakanishi, H.,
Miyahara, M.,
Mandai, K.,
Satoh, K.,
Satoh, A.,
Nishioka, H.,
Aoki, N.,
Mizoguchi, A.,
and Takai, Y.
(1999)
J. Cell Biol.
145,
539-549 17.
Mandai, K.,
Nakanishi, H.,
Satoh, A.,
Takahashi, K.,
Satoh, K.,
Nishioka, H.,
Mizoguchi, A.,
and Takai, Y.
(1999)
J. Cell Biol.
144,
1001-1017 18.
Mandai, K.,
Nakanishi, H.,
Satoh, A.,
Obaishi, H.,
Wada, M.,
Nishioka, M.,
Itoh, M.,
Mizoguchi, A.,
Aoki, T.,
Fujimoto, T.,
Matsuda, Y.,
Tsukita, S.,
and Takai, Y.
(1997)
J. Cell Biol.
139,
517-528 19.
Miyahara, M.,
Nakanishi, H.,
Takahashi, K.,
Satoh-Horikawa, K.,
Tachibana, K.,
and Takai, Y.
(2000)
J. Biol. Chem.
275,
613-618 20.
Ikeda, W.,
Nakanishi, H.,
Miyoshi, J.,
Mandai, K.,
Ishizaki, H.,
Tanaka, M.,
Togawa, A.,
Takahashi, K.,
Nishioka, H.,
Yoshida, H.,
Mizoguchi, A.,
Nishikawa, S.,
and Takai, Y.
(1999)
J. Cell Biol.
146,
1117-1131 21.
Tachibana, K.,
Nakanishi, H.,
Mandai, K.,
Ozaki, K.,
Ikeda, W.,
Yamamoto, Y.,
Nagafuchi, A.,
Tsukita, S.,
and Takai, Y.
(2000)
J. Cell Biol.
150,
1161-1175 22.
Sakisaka, T.,
Nakanishi, H.,
Takahashi, K.,
Mandai, K.,
Miyahara, M.,
Satoh, A.,
Takaishi, K.,
and Takai, Y.
(1998)
Oncogene
18,
1609-1617
23.
Nagafuchi, A.,
Takeichi, M.,
and Tsukita, S.
(1991)
Cell
65,
849-857[CrossRef][Medline]
[Order article via Infotrieve]
24.
Herrenknecht, K.,
Ozawa, M.,
Eckerskorn, C.,
Lottspeich, F.,
Lenter, M.,
and Kemler, R.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
9156-9160 25.
Pokutta, S.,
and Weis, W. I.
(2000)
Mol. Cell
5,
533-543[CrossRef][Medline]
[Order article via Infotrieve]
26.
Bakolitska, C.,
de Pereda, J. M.,
Bagshaw, C. R.,
Critchley, D. R.,
and Liddington, R. C.
(1999)
Cell
99,
603-613[CrossRef][Medline]
[Order article via Infotrieve]
27.
Yang, J.,
Dokurno, P.,
Tonks, N. K.,
and Barford, D.
(2001)
EMBO J.
20,
3645-3656[CrossRef][Medline]
[Order article via Infotrieve]
28.
Aberle, H.,
Butz, S.,
Stappert, J.,
Weissig, H.,
Kemler, R.,
and Hoschuetzky, H.
(1994)
J. Cell Sci.
107,
3655-3663[Abstract]
29.
Guan, K. L.,
and Dixon, J. E.
(1991)
Biochemistry
192,
262-267
30.
Otwinowski, Z.,
and Minor, W.
(1997)
Methods Enzymol.
276,
307-326
31.
Brünger, A. T.,
Adams, P. D.,
Clore, G. M.,
Gros, P.,
Grosse-Kunstleve, R. W.,
Jiang, J.-S.,
Kuszewsky, J.,
Nilges, M.,
Pannu, N. S.,
Read, R. J.,
Rice, L. M.,
Simoson, T.,
and Warren, G. L.
(1998)
Acta Crystallogr. Sect. D Biol. Crystallogr.
54,
905-921[CrossRef][Medline]
[Order article via Infotrieve]
32.
Jones, T. A.,
Zou, J.-Y.,
Cowan, S. W.,
and Kjeldgaard, M.
(1991)
Acta Crystallogr. Sect. A
47,
110-119[CrossRef]
33.
Lo Conte, L.,
Chothia, C.,
and Janin, J.
(1999)
J. Mol. Biol.
285,
2177-2198[CrossRef][Medline]
[Order article via Infotrieve]
34.
Koslov, E. R.,
Maupin, P.,
Pradhan, D.,
Morrow, J. S.,
and Rimm, D. L.
(1997)
J. Biol. Chem.
272,
27301-27306 35.
Knudsen, K. A.,
Soler, A. P.,
Johnson, K. R.,
and Wheelock, M. J.
(1995)
J. Cell Biol.
130,
67-77 36.
Craig, S. W.,
and Johnson, R. P.
(1995)
Nature
373,
261-264[CrossRef][Medline]
[Order article via Infotrieve]
37.
Tsukita, S.,
Yonemura, S.,
and Tsukita, S.
(1997)
Trends Biol. Sci.
22,
53-58
38.
Pearson, M. A.,
Reczek, D.,
Bretscher, A.,
and Karplus, P. A.
(2000)
Cell
101,
259-270[CrossRef][Medline]
[Order article via Infotrieve]
39.
Kraulis, P. J.
(1991)
J. Appl. Crystallogr.
24,
946-950[CrossRef]
40.
Merritt, E. A.,
and Murphy, M. E. P.
(1994)
Acta Crystallogr. Sect. D Biol. Crystallogr.
50,
869-873[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
K. Kuramitsu, W. Ikeda, N. Inoue, Y. Tamaru, and Y. Takai Novel role of nectin: implication in the co-localization of JAM-A and claudin-1 at the same cell-cell adhesion membrane domain. Genes Cells, August 1, 2008; 13(8): 797 - 805. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Xie, H. Photowala, M. E. Cahill, D. P. Srivastava, K. M. Woolfrey, C. Y. Shum, R. L. Huganir, and P. Penzes Coordination of Synaptic Adhesion with Dendritic Spine Remodeling by AF-6 and Kalirin-7 J. Neurosci., June 11, 2008; 28(24): 6079 - 6091. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Mruk, B. Silvestrini, and C. Y. Cheng Anchoring Junctions As Drug Targets: Role in Contraceptive Development Pharmacol. Rev., June 1, 2008; 60(2): 146 - 180. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Komura, H. Ogita, W. Ikeda, A. Mizoguchi, J. Miyoshi, and Y. Takai Establishment of cell polarity by afadin during the formation of embryoid bodies. Genes Cells, January 1, 2008; 13(1): 79 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Goossens, B. Janssens, G. Vanpoucke, R. De Rycke, J. van Hengel, and F. van Roy Truncated isoform of mouse {alpha}T-catenin is testis-restricted in expression and function FASEB J, March 1, 2007; 21(3): 647 - 655. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. I. Weis and W. J. Nelson Re-solving the Cadherin-Catenin-Actin Conundrum J. Biol. Chem., November 24, 2006; 281(47): 35593 - 35597. [Full Text] [PDF] |
||||
![]() |
M. Lorger and K. Moelling Regulation of epithelial wound closure and intercellular adhesion by interaction of AF6 with actin cytoskeleton J. Cell Sci., August 15, 2006; 119(16): 3385 - 3398. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sato, N. Fujita, A. Yamada, T. Ooshio, R. Okamoto, K. Irie, and Y. Takai Regulation of the Assembly and Adhesion Activity of E-cadherin by Nectin and Afadin for the Formation of Adherens Junctions in Madin-Darby Canine Kidney Cells J. Biol. Chem., February 24, 2006; 281(8): 5288 - 5299. [Abstract]< |